58.49k followers • 23 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Green Thumb Industries Acquires For Success Holding CompanyGreen Thumb Industries closes its acquisition of For Success Holding Company Today, in a press release, Green Thumb Industries (GTBIF) announced that it has completed its acquisition of For
GILD or ABBV: Which Is a Better Biotech Pick This Month?(Continued from Prior Part)EPS guidance for 2019In its fourth-quarter earnings presentation, Gilead Sciences (GILD) guided for a GAAP (generally accepted accounting principles) to non-GAAP
Today's Gains and Losses in the Cannabis Sector: Mid-Day UpdateCannabis stock lossesToday remained mixed for the cannabis sector with some major stocks continuing to decline at around 11:55 AM ET. Canopy Growth (WEED)(CGC) continued to trend lower
Why CannTrust Is Trending Higher in February(Continued from Prior Part)CannTrust’s valuationsCannabis stocks (HMMJ) experienced a steep sell-off in December along with the broader markets. This sell-off led to the companies in the cannabis sector
GILD or ABBV: Which Is a Better Biotech Pick This Month?Share price movements On February 15, Gilead Sciences (GILD) closed at $67.59, 1.84% higher than its previous closing price, 12.05% higher than its 52-week low of $60.32, and 18.29% lower than
Why CannTrust Is Trending Higher in February(Continued from Prior Part)Analyst ratingsEarlier in this series, we discussed how CannTrust (CNTTF) has performed so far this year in 2019. The stock is all set to up-list on the New York Stock Exchange
Tilray's deal to acquire the hemp food maker Manitoba Harvest has bolstered the outlook of the already high-flying marijuana ETF.
Canopy Growth Restates Earnings Figure, Stock SinksCanopy Growth On February 20, Canopy Growth (WEED) (CGC) issued a press release saying that it had reported an incorrect number for adjusted EBITDA for the nine months that ended on December 31,
Why CannTrust Is Trending Higher in FebruaryCannTrust’s gains CannTrust (CNTTF) has been trending higher ever since the beginning of this year. The stock has returned nearly 75% YTD as of February 20. In February alone, the company returned about
Canopy Growth's CEO and CFO talk cannabis-infused beverages, when the company's hemp-derived CBD products could be available in the U.S., and more.
How Charlotte’s Web Holdings’ Upside Potential Compares to PeersAnalystsCharlotte’s Web Holdings (CWBHF) has received a “strong buy” rating from one analyst, while three analysts polled by Thomson Reuters on February 20 have rated it as a
Analysts' Ratings for ACB, CRON, and APHA in February(Continued from Prior Part)Aphria Last week, Aphria’s (APHA) board provided some relief to investors with its findings on the LATAM asset acquisitions. While the board did find conflicts in the
Analysts' Ratings for ACB, CRON, and APHA in February(Continued from Prior Part)Aurora CannabisAurora Cannabis (ACB) has been almost flat since it reported its earnings on February 11. To learn more about the company’s earnings, read Aurora
Tilray's acquisition of the world's largest hemp food company could give the Canadian marijuana producer an edge over its top rivals.
Tilray to Acquire Manitoba HarvestTLRY moves higherEarly on February 20, Tilray (TLRY) was moving higher after it announced the acquisition of Manitoba Harvest. The purchase price for Manitoba Harvest was 419 million Canadian dollars, and the
Analysts' Ratings for ACB, CRON, and APHA in February(Continued from Prior Part)Cronos Group Cronos Group (CRON) hasn’t reported its earnings yet. Cronos Group has been one of the top choices for investors (HMMJ) along with Canopy Growth (WEED),
AbbVie's (ABBV) new drug application for its late-stage candidate, upadacitinib, gets a priority review status from the FDA for treating rheumatoid arthritis in adult patients.